Top Banner
1 Ivabradine: Ivabradine: Is there a cardiovascular Is there a cardiovascular benefit to pure heart benefit to pure heart rate reduction? rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD
54

1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

Dec 26, 2015

Download

Documents

Kory Wiggins
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

1

Ivabradine: Ivabradine: Is there a cardiovascular benefit to Is there a cardiovascular benefit to pure heart rate reduction?pure heart rate reduction?

Catheterization Conference

October 27, 2011

Anit Mankad, MD

Page 2: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

2

By Harlan Jay Ellison (1965)

“Heart Beat Hypothesis”

Page 3: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

3

Overview

Beta BlockersActivity, impact, intolerance

Adrenergic (sympathetic) activityIf current and “Funny” Channels

IvabradineEarly trials BEAUTIFUL and SHIFT trialsCurrent indications outside the U.S.

Future considerations

Page 4: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

4

Case

55 yo WM, PMH history of CAD s/p previous PCI, Ischemic cardiomyopathy, EF 35%, Severe COPD with frequent use of inhalers, comes to your clinic for follow-up, describing low grade stable angina for months (since PCI).

On metoprolol 6.25mg bid, amlodipine 10mg, asa, plavix, statin, ISMN 60mg

BP 110/60, HR 88 at rest. What can we offer him?

Page 5: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

5

Elevated Resting Heart Rate Accelerates production of atherosclerosis (Int J

Cardiol 2008;126:302-12)

Associated with coronary plaque disruption (Circulation 2001;126:1477-82)

Framingham Studyprogressive increase in all cause and cardiovascular

mortality in relation to antecedent HR (Am Heart J 1987; 113:1489-94)

Continuous increase in death rates in survivors of Acute MIstarting at HR > 70 (J Am Coll Cardiol 2007;50:823-30)

Page 6: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

6

Mechanism of Consequences of Elevated Resting Heart Rate

Increases myocardial oxygen demand Decreases myocardial perfusion by reducing

diastolic perfusion time (Circulation 1979;60:164-9)

Causes vasoconstriction of diseased coronary arteriesSambuceti et al. (Circulation. 1997; 95: 2652-9)

○ 10 patients found to have LAD stenosis (mean 80±5%) vs 7 controls with atypical chest pain, no significant CAD.

○ Pacer lead in RA, flow wire to calculate coronary resistance index○ AdenosinePacing (increments of 20bpm increase)

Adenosine

Page 7: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

7

.

Sambuceti G et al. Circulation 1997;95:2652-2659

Page 8: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

8

Heart Rate in Cardiovascular Outcomes

Diaz et al. 25,000 patients who had cardiac cath requests for

suspected or proven CADDivided heart rate into quintilesMultivariable Cox PH models

○ Adjusted for beta-blockers use As well as smoking, DM, HTN, gender, age, EF, antiplatelet

and lipid agents

Page 9: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

9

Page 10: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

10

Page 11: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

11

Page 12: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

12

Page 13: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

13

Page 14: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

14

Beta-Adrenoceptors Endogenous

catecholamines

activate B-receptors

(Adenylate Cyclase)

Increased cAMP

Increased Ca++ influx

Inotropic Chronotropic

Page 15: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

15

Beta Blockers (BB) B1negative chronotropy and inotropyAV conduction delayReduced atrial and ventricular arrythmias

B2BronchoconstrictionPeripheral unopposed alpha constrictionDecrease glycogenolysis

- (contribute to hypoglycemic events) Other antagonize release of renin reduces intraocular pressures

Page 16: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

16

Impact of BB

Acute MINorwegian Multicenter

Study Group Timolol *CAPRICORN †ISIS-1 ‡

CHFCOPERNICUS £MERIT-HF €

Page 17: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

17

Intolerence of BB Side effects

Bronchoconstriction, AV delay, hypoglycemiaWeight gain, depression, fatigue

BB may not be tolerated in high enough doses to attain heart rates below 70bpm

Acute setting (Acute MI, or CHF), the negative inotropic effect could be deleteriousThis has been shown in dogs (Eur Heart J (2004) 25 (7): 579-586

Page 18: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

18

Autonomic Nervous System

Page 19: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

19

If Current

Sinoatrial Node NA-K inward current Regulated by the

Funny ChannelcAMP

H.F.Brown (1979)• means for acceleration of diastolic depolarization (heart

rate) in adrenergic response

Page 20: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

20

Page 21: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

21

Autonomic Nervous System

Page 22: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

22

Ivabradine Specifically binds the Funny

channelReduces the slope for diastolic

depolarization ○ Prolongs diastolic duration

Does not alter…○ Ventricular repolarization○ Myocardial contractility○ Blood pressure

Page 23: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

23

Ivabradine

2005--Approved by the European Medicine Agency Trade: Procoralan, Coralan (India), Corlentor (Italy)

2.5mg, 5mg, 7.5mg. Two times a day

Side Effects (%) Teratogenic

PregnancyBreast feeding

Page 24: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

24

Early Studies

Page 25: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

25

Heart rate Reduction during Exercise-inducedMyocardial Ischemia and Stunning

5 dogs with implanted LCx occluder, ultrasound crystals (LV wall thickness), and pacerIvabradine vs atenolol vs saline

○ Administered before or after 10min on treadmill ○ Paced at 150bpm for 6 hours

Page 26: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

26Monnet X et al. Eur Heart J 2004;25:579-586

*P<0.05: atenolol and ivabradine significantly different from saline.

Saline (full circles) Ivabradine (open circles) Atenolol (open triangles)

Administration BEFORE Onset of Exercise

Page 27: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

27

Monnet X et al. Eur Heart J 2004;25:579-586

*P<0.05: atenolol and ivabradine significantly different from saline. †P<0.05: atenolol significantly different from ivabradine.

Saline (full circles) Ivabradine (open circles) Atenolol (open triangles)

Administration BEFORE Onset of Exercise AND PACED

Page 28: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

28

Monnet X et al. Eur Heart J 2004;25:579-586

Administration AFTER Onset of Exercise

*P<0.05: atenolol and ivabradine significantly different from saline. †P<0.05: atenolol significantly different from ivabradine.

Saline (full circles) Ivabradine (open circles) Atenolol (open triangles)

Page 29: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

29

Monnet X et al. Eur Heart J 2004;25:579-586

*P<0.05: atenolol and ivabradine significantly different from saline. †P<0.05: atenolol significantly different from ivabradine.

Administration AFTER Onset of ExerciseAND PACED

Saline (full circles) Ivabradine (open circles) Atenolol (open triangles)

Page 30: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

30

Ivabradine Trials

Reduces atherosclerosis (Circ 2008;117:2377-87)

Decreases vascular oxidative stressImproves endothelial function

Increases exertional tolerance and time to ischemia in patients with > 3 months angina (Circ 2003;107:817-23)

Non-inferior to Atenolol (Eur Heart J 2005;26:2529-36)

Exercise tolerance, time to angina or ischemia Non-inferior to Amlodipine (Drugs 2007;67(3):393-405)

Page 31: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

31

BEAUTIFUL Trial Randomized, double-blinded, placebo controlled

781 centers, 33 countries 11,000 subjects (between 2005 and 2007)

Male (98%), Caucasian (83%), HR>60, EF<40%CAD and on optimal medical management

○ 87% on BB, 89% on ACE/ARBs, 27% Aldo antagonists

Ivabradine vs placebo, followed for 3 years5mg bid, if HR >60 at 2 weeks, increase to 7.5mg

Primary endpoint was a composite of CV death and hospitalizations for MI or CHF

Subgroup analysis: HR>70 (5,400)

Page 32: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

32

Page 33: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

33

CV Death/ Heart Failure Admissions(HR >60)

Page 34: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

34

CV Death/ Heart Failure Admissions(HR >70)

Page 35: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

35

Heart Failure Admissions(HR >70)

Page 36: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

36

Acute MI Admissions(HR >70)

Page 37: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

37

Proportion Requiring PCI(HR >70)

Page 38: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

38

What Can We Conclude from the BEAUTIFUL Trial?

While there was no difference total cardiovascular mortality

Ivabradine use appears to be a benefit in reducing readmissions due to coronary artery disease (when resting heart rate > 70)1. Acute Myocardial Infarction

2. Coronary Revascularization

Page 39: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

39

SHIFT Trial Randomized, double-blinded, placebo controlled 6,500 subjects

Male (76%), Caucasian (89%)Class II – IV heart failure, EF<35%, HR>70bpmAdmission for heart failure in the previous 2 months

On optimal medical management○ 90% on BB, 84% on ACE/ARBs, 60% Aldo antagonists

Ivabradine vs placebo, followed for 3 years Primary endpoint: composite of CV death or

hospital admission for heart failure.

Page 40: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

40

Beta Blocker use in SHIFT

Page 41: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

41

Page 42: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

42

Page 43: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

43

Cardiovascular Death and Heart Failure Admissions

Page 44: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

44

Heart Failure Admissions

Page 45: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

45

Cardiovascular Mortality

Page 46: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

46

Deaths due to Heart Failure

Page 47: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

47

SHIFT Echo substudy

Page 48: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

48

What Can We Conclude from the SHIFT Trial?

In patients with all-cause cardiomyopathy (EF<35%), and heart rates > 70bpm,

While there was no difference total cardiovascular mortality,

Ivabradine reduces… 1. Mortality due to Heart Failure

2. Heart failure admissions

Page 49: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

49

Current IndicationsEuropean Medicines Agency

“Treatment of symptoms of long-term stable angina in adults (aged over 18 years) with coronary artery disease who have normal sinus rhythm.

It can be used in the following groupsPatients who cannot take or tolerate beta-blockersPatients whose disease is not controlled with beta-

blockers and whose heart rate is above 60bpm.”

Page 50: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

50

Future Considerations

Use of Ivabradine in the acute settingAcute myocardial infarctionUpon onset of congestive heart failure?

Diastolic heart failure?

Page 51: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

51

Summary

Ivabradine is a selective inhibitor of “Funny” (If) Current in the sinoatrial node.

It causes a pure heart rate reduction.

It is shows cardiovascular benefit when given addition to optimal medical management.

Page 52: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

52

Summary Ivabradine use reduces readmissions due to

coronary artery disease (when resting heart rate > 70, EF<40%)1. Acute Myocardial Infarction

2. Coronary Revascularization

In patients with all-cause cardiomyopathy (EF<35%), and heart rates > 70bpm,

Ivabradine reduces… 1. Mortality due to Heart Failure

2. Heart Failure Admissions

Page 53: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

53

Case

55 yo WM, PMH history of CAD s/p previous PCI, Ischemic cardiomyopathy, EF 35%, Severe COPD with frequent use of inhalers, comes to your clinic for follow-up, describing low grade stable angina for months (since PCI).

On metoprolol 6.25mg bid, amlodipine 10mg, asa, plavix, statin, ISMN 60mg

BP 110/60, HR 88 at rest. What can we offer him? Ivabradine

Page 54: 1 Ivabradine: Is there a cardiovascular benefit to pure heart rate reduction? Catheterization Conference October 27, 2011 Anit Mankad, MD.

54

Thank You!